Administrative AI can meaningfully cut providers’ price tags on prior authorization processes. Yet the technology is not doing much to reduce overall system-level costs. And it tends to increase billing intensity, inflating medical spending as it does so.
The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.
However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape.
Medmo and Covera Health, both based in New York, officially announced their merger on April 21, with the latter’s lead investor, Insight Partners, funding the deal.
Speaking at a Politico health care policy forum, CMS Administrator Mehmet Oz, MD, said he supports Medicaid, adding that “when you love something, you protect it.”
The insurance giant has been piloting a program to speed up reimbursement to hospitals in 10 states, reducing delays by roughly 50%. Now, the company said it will work to lift prior authorization barriers on patient care delivery. The intent is to roll out these changes nationwide by the end of 2026, UnitedHealthcare confirmed.
Administrative AI can meaningfully cut providers’ price tags on prior authorization processes. Yet the technology is not doing much to reduce overall system-level costs. And it tends to increase billing intensity, inflating medical spending as it does so.
